invoX Pharma Limited clinical trials
A subsidiary of Sino Biopharmaceutical Limited
The registry lists 4 studies whose lead sponsor is invoX Pharma Limited. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 1, 2025.
Registry sponsor names on this page
- invoX Pharma Limited4 studies
Something wrong with this grouping? Tell us on the Sino Biopharmaceutical Limited page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Sino Biopharmaceutical Limited studies →
- FS222 First in Human Study in Patients With Advanced MalignanciesRecruitingNCT04740424Phase 1
Sponsor listed in the registry: invoX Pharma Limited
- A Phase 1/2 Study of FS118 in Patients With Advanced MalignanciesTerminatedNCT03440437Phase 1/2
Sponsor listed in the registry: invoX Pharma Limited
- FS120 Phase 1/1b Study in Patients With Advanced MalignanciesActive, not recruitingNCT04648202Phase 1
Sponsor listed in the registry: invoX Pharma Limited
- Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid TumorsCompletedNCT04096638Phase 1
Sponsor listed in the registry: invoX Pharma Limited